Ignite Creation Date:
2025-12-24 @ 4:35 PM
Ignite Modification Date:
2025-12-29 @ 2:03 AM
Study NCT ID:
NCT00396266
Status:
COMPLETED
Last Update Posted:
2014-03-07
First Post:
2006-11-02
Is NOT Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
AMD3100 (Plerixafor) Given to NHL and MM Patients to Increase the Number of PBSCs When Given a Mobilizing Regimen of G-CSF
Sponsor:
Genzyme, a Sanofi Company
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2005-01
Start Date Type:
None
Primary Completion Date:
2007-12
Primary Completion Date Type:
ACTUAL
Completion Date:
2007-12
Completion Date Type:
ACTUAL
First Submit Date:
2006-11-02
First Submit QC Date:
None
Study First Post Date:
2006-11-06
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
2010-10-30
Results First Submit QC Date:
None
Results First Post Date:
2010-11-25
Results First Post Date Type:
ESTIMATED
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2014-02-04
Last Update Post Date:
2014-03-07
Last Update Post Date Type:
ESTIMATED